AG003SOX

3102-57-6 | C2 Ceramide (d18:1/2:0)

Chemical structure of C2 Ceramide (d18:1/2:0), CAS 3102-57-6
AG003SOX
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 3102-57-6
Catalog Number AG003SOX(AGN-PC-0R6E5V)
Chemical Name C2 Ceramide (d18:1/2:0)
IUPAC Name N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]acetamide
InChI InChI=1S/C20H39NO3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-20(24)19(17-22)21-18(2)23/h15-16,19-20,22,24H,3-14,17H2,1-2H3,(H,21,23)/b16-15+/t19-,20+/m0/s1
InChI Key BLTCBVOJNNKFKC-QUDYQQOWSA-N
MDL Number MFCD00153903
Molecular Formula C20H39NO3
Molecular Weight 341.5286
SMILES CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](NC(C)=O)CO
UNII 8YTC7R47CW
Synonyms
C2-ceramide, N-acetylsphingosine, N-acetylsphingosine, C2 ceramide, C2-ceramide, 3102-57-6, N-(acetyl)-sphing-4-enine, UNII-8YTC7R47CW, 8YTC7R47CW, CHEBI:46979, Cer(d18:1/2:0), D-erythro-Sphingosine, N-Acetyl-, N-Acetyl-D-sphingosine, N-acetoyl-D-erythro-sphingosine, C2 Ceramide (d18:1/2:0), Acetamide, N-(2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl)-, (R-(R*,S*-(E)))-, 195194-58-2, C2ceramide, MFCD00153903, Acetamide, N-[2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-, [R-[R*,S*-(E)]]-, N-Acetylspingosine, C-2 Ceramide, C2-cer, N-(acetyl)-ceramide, AC1NUZJL, D-erythro-C2-Ceramide, C2:0 CERAMIDE, N-[(2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]acetamide, Cer(d20:1), BSPBio_001565, D-erythro-N-Acetylsphingosine, D-erythro-N-acetyl-sphingosine, N-acetyl-D-erythro-sphingosine, BML3-C10, CHEMBL105867, SCHEMBL1191825, C20H39NO3, CHEBI:92736, BLTCBVOJNNKFKC-QUDYQQOWSA-N, HMS1361O07, HMS1791O07, HMS1989O07, HMS3402O07, HMS3649E05, HMS3675F19, ZINC8830550, 1646AH, CMC_12038, CMC_12046, CMC_12047, HSCI1_000073, LMSP02010014, AKOS015915613, EBD2217018, IDI1_034035, NCGC00024763-03, LS-186922, LS-187572, SR-01000597683, SR-01000946564, J-018227, SR-01000597683-1, SR-01000946564-1, BRD-K41707108-001-02-3, BRD-K41707108-001-03-1, I14-53272, D-erythro-1,3-Dihydroxy-2-acetamido-trans-4-octadecene, N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]acetamide, N-[(E,2S,3R)-1,3-dihydroxyoctadec-4-en-2-yl]acetamide, C2 Ceramide (d18:1/2:0), N-acetoyl-D-erythro-sphingosine, powder, acetamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-, Acetamide,N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]-, N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecen-1-yl]acetamide, Acetamide, N-[(1S,2R,3E)-2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]- (9CI), Acetamide, N-[2-hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-, (E)-D-erythro- (8CI), ceramide, Acetyl ceramide, C(2)-ceramide, N-acetyldihydrosphingosine, DY131, C20-H39-N-O3, CID5497136, C064769, (2S,3R,4E)-2-(Acetylamino)-4-octadecene-1,3-diol, 95167-41-2,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited